These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The cyclins: a family of widely expressed tumor antigens?
    Author: von Bergwelt-Baildon MS, Kondo E, Klein-González N, Wendtner CM.
    Journal: Expert Rev Vaccines; 2011 Mar; 10(3):389-95. PubMed ID: 21434806.
    Abstract:
    Continuous cell division is a hallmark of cancer and cell-cycle regulators therefore represent relevant target molecules for tumor therapy. Among these targets the cyclins are of particular interest as they are overexpressed in various tumor entities with little expression in normal tissue. Here we review evidence that these molecules are recognized by the immune system, summarize why cyclins A, B and D in particular appear to be interesting targets for active and passive immunotherapy, and discuss whether the entire family could be an interesting novel class of tumor antigens for cancer treatment and prevention.
    [Abstract] [Full Text] [Related] [New Search]